The new name, effective April 1, 2022, for the company that announced a trade name change is Sumitomo Pharma Co., Ltd.
Details of the Name Change
On April 1, 2022, Sumitomo Pharma Co., Ltd. announced that it officially changed its trade name to "Sumitomo Pharma Co., Ltd.". This marks an important update in the company's official corporate identity. The announcement was made by Sumitomo Pharma Co., Ltd., which has its head office in Osaka, Japan, and is led by Representative Director, President and CEO Hiroshi Nomura.
Historical Context of Sumitomo Pharma
The company's lineage in the pharmaceutical industry dates back further. A significant event in its history occurred in October 2005 when Sumitomo Pharmaceuticals Co., Ltd. and Dainippon Pharmaceutical Co., Ltd. were involved in a pivotal development. This historical context provides background to the current entity known as Sumitomo Pharma Co., Ltd.
To summarize the key information regarding the name change and historical context:
| Event/Entity | Date | Description |
|---|---|---|
| New Trade Name Effective | April 1, 2022 | Sumitomo Pharma Co., Ltd. (as announced by the company itself) |
| Historical Merger/Formation | October 2005 | Involved Sumitomo Pharmaceuticals Co., Ltd. and Dainippon Pharmaceutical Co., Ltd., laying the groundwork for the modern entity related to the current Sumitomo Pharma Co., Ltd. |
This change reflects the ongoing evolution of the company within the global pharmaceutical sector, aligning its official trade name with its current operations and branding.
